Adherence to international recommendations in the governance and organisation of Nordic cervical cancer screening programmes

• Published in: Acta oncologica 2020-11, Vol.59 (11), p.1308-1315
• Main Authors: Partanen, Veli-Matti, Heinävaara, Sirpa, Waldstrøm, Marianne, Elfström, Klara Miriam, Tropé, Ameli, Ágústsson, Ágúst Ingi, Thorsteinsdottir, Svanhildur, Skare, Gry Baadstrand, Lönnberg, Stefan
• Format: Article
• Language: English
• Subjects: adherence; Cervical cancer; governance; Medicin och hälsovetenskap; recommendations; screening
• ISSN: 0284-186X; 1651-226X; 1651-226X
• DOI: 10.1080/0284186X.2020.1821089

Screening has been the primary reason for the decline in the incidence and mortality of cervical cancer in the Nordic countries since the beginning of screening in the 1960s. Recently, the incidence of cervical cancer has increased in the Nordic countries indicating the need to look closely at possibilities for further improvement in screening. This article provides an overview of cervical cancer screening programmes in the Nordic countries and whether the programmes adhere to international recommendations. Relevant and unambiguous screening recommendations were extracted from applicable literature and classified into legal framework, governance, organisation, and monitoring and evaluation. The up-to-date status of screening programmes and adherence to selected recommendations was gathered from official documentation and co-authors representing cervical cancer screening programmes in all the Nordic countries. A total of 168 recommendations were extracted and 54 of them were considered to be unambiguous and relevant. Forty-nine recommendations were included after synthesising similar recommendations. All Nordic countries adhere to recommendations related to legal framework, but adherence was lower with recommendations related to governance and organisation of screening. Monitoring and evaluation are also areas where adherence to recommendations could be improved. The Nordic cervical cancer screening programmes have substantially decreased cancer burden despite not fully adhering to many of the recommendations. The presented gaps in adherence suggest that there is room for improvement in the screening programmes. Establishing clearer governance structures would still increase the ability to manage changes such as implementing HPV testing as the primary screening method or modifying the programme when HPV vaccinated cohorts of women enter the target age for screening.